Despite advancements in women’s health diagnostics, cervical cancer screening rates remain critically low due to the invasive nature of traditional collection methods like Pap smears and self-swabs. CELLECT is pioneering a non-invasive, nanotechnology-enabled collection device—the CELLECTPad—that passively captures high-quality cervical and epithelial cells during menstruation. By removing the discomfort and accessibility barriers of existing methods, […]
Read More